Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
9,38 USD | +1,79 % | -4,67 % | +15,23 % |
18/04 | Verastem Oncology annonce des changements à la direction | CI |
14/03 | Verastem, Inc. annonce ses résultats pour l'exercice terminé le 31 décembre 2023 | CI |
Métier
Nombre d'employés: 73
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Dan Paterson
CEO | Chief Executive Officer | 63 | 01/01/11 |
Daniel Calkins
DFI | Director of Finance/CFO | 37 | 01/12/18 |
Jonathan Pachter
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/07/11 |
Brian Stuglik
BRD | Director/Board Member | 64 | 02/09/17 |
Michael Crowther
PRN | Corporate Officer/Principal | - | 26/10/23 |
Corporate Officer/Principal | 67 | 19/01/17 | |
Cathy Carew
PRN | Corporate Officer/Principal | - | - |
David Mitchell
LAW | General Counsel | 67 | 26/10/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 67 | 03/05/17 |
John Johnson
BRD | Director/Board Member | 66 | 23/04/20 |
Michael Kauffman
CHM | Chairman | 60 | 26/11/12 |
Dan Paterson
CEO | Chief Executive Officer | 63 | 01/01/11 |
Paul Bunn
BRD | Director/Board Member | 79 | 24/06/21 |
Anil Kapur
BRD | Director/Board Member | 54 | 20/10/22 |
Robert Gagnon
BRD | Director/Board Member | 49 | 13/12/22 |
Karin Tollefson
BRD | Director/Board Member | 57 | 15/05/23 |
Brian Stuglik
BRD | Director/Board Member | 64 | 02/09/17 |
Director/Board Member | 57 | 15/11/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 25 307 669 | 25 163 000 ( 99,43 %) | 0 | 99,43 % |
Action B | 0 | 1 200 000 | 0 | 0 |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+15,23 % | 237 M | |
-2,31 % | 103 Md | |
+0,56 % | 95,28 Md | |
+1,69 % | 22,15 Md | |
-17,37 % | 21,02 Md | |
-9,30 % | 18,15 Md | |
-41,01 % | 16,73 Md | |
-14,85 % | 16,05 Md | |
+3,21 % | 13,68 Md | |
+33,54 % | 12,17 Md |
- Bourse
- Actions
- Action VSTM
- Société Verastem, Inc.